Transcode Therapeutics, Inc. (RNAZ) (CIK 0001829635) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001104659-25-122526
- Form
- CORRESP
- Filer
- Transcode Therapeutics, Inc. (RNAZ) (CIK 0001829635)
- CIK
- 0001829635
- Ticker
- RNAZ
- Filed
- 2025-12-18
- SIC industry
- 2834
- HQ
- Boston, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1829635/000110465925122526/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗